September 11, 2019
Targeting therapy to each patient’s unique cancer
By Advancing the Science contributor
Article by Sara Damore As DNA sequencing technology helps bring genetic factors driving disease into focus, researchers have developed new cancer therapies to target a patient’s unique cancer, especially for those who do not respond to standard therapy. Funda Meric-Bernstam, M.D., a physician-scientist at MD Anderson Cancer Center, will speak on Decision Support for Precision […]
Tags: Alan Bryce, cancer, Center for Individualized Medicine, clinical trials, DNA, genomics, hematology, Mayo Clinic Cancer Center, oncology, personalized medicine
January 30, 2018
How does a genomic tumor board impact patient care?
The outcomes from a Mayo Clinic study published in Oncotarget found value in having an established genomic tumor board, and using genomics for certain patients. The experience of the Genomic Tumor Board has promoted an evolution in the practice according to Alan Bryce, M.D., a Mayo Clinic oncologist, and co-first author on the study. “There is an emerging […]
Tags: Alan Bryce, cancer, Center for Individualized Medicine, genetic testing, genomics, Jan Egan, Mayo Clinic Cancer Center, tumor